NCT01906853View on ClinicalTrials.gov

Melbourne Infant Study - Bacille Calmette Guérin (BCG) for Allergy & Infection Reduction

PHASE3CompletedINTERVENTIONAL
Enrollment

1,272

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2023

Study Completion Date

February 28, 2025

Conditions
AllergyEczemaRespiratory Tract Infections
Interventions
BIOLOGICAL

BCG

Trial Locations (2)

3052

Royal Children's Hospital, Melbourne

3084

Mercy Hospital for Women, Heidelberg

Sponsors
All Listed Sponsors
collaborator

Royal Children's Hospital

OTHER

collaborator

Mercy Hospital for Women, Australia

OTHER

collaborator

University of Melbourne

OTHER

lead

Murdoch Childrens Research Institute

OTHER